DERMAPHARM HOLDING SE (DMP.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:DMP - DE000A2GS5D8 - Common Stock
38.25 EUR
-0.5 (-1.29%)
Taking everything into account, DMP scores 5 out of 10 in our fundamental rating. DMP was compared to 55 industry peers in the Pharmaceuticals industry. DMP has an average financial health and profitability rating. DMP has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
DMP had positive earnings in the past year.
DMP had a positive operating cash flow in the past year.
DMP had positive earnings in each of the past 5 years.
DMP had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
DMP has a Return On Assets of 5.48%. This is comparable to the rest of the industry: DMP outperforms 50.91% of its industry peers.
The Return On Equity of DMP (17.87%) is better than 61.82% of its industry peers.
With a Return On Invested Capital value of 7.26%, DMP perfoms like the industry average, outperforming 47.27% of the companies in the same industry.
DMP had an Average Return On Invested Capital over the past 3 years of 9.78%. This is below the industry average of 13.65%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.48% | ||
| ROE | 17.87% | ||
| ROIC | 7.26% |
ROA(3y)5.95%
ROA(5y)7.95%
ROE(3y)18.55%
ROE(5y)24.89%
ROIC(3y)9.78%
ROIC(5y)10.35%
1.3 Margins
Looking at the Profit Margin, with a value of 10.00%, DMP is in line with its industry, outperforming 45.45% of the companies in the same industry.
DMP's Profit Margin has declined in the last couple of years.
DMP has a Operating Margin (18.70%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of DMP has grown nicely.
DMP has a worse Gross Margin (66.57%) than 60.00% of its industry peers.
DMP's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.7% | ||
| PM (TTM) | 10% | ||
| GM | 66.57% |
OM growth 3Y-14.93%
OM growth 5Y2.07%
PM growth 3Y-24.31%
PM growth 5Y-2.64%
GM growth 3Y-0.44%
GM growth 5Y3.48%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so DMP is still creating some value.
DMP has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for DMP remains at a similar level compared to 5 years ago.
Compared to 1 year ago, DMP has a worse debt to assets ratio.
2.2 Solvency
DMP has an Altman-Z score of 2.26. This is not the best score and indicates that DMP is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.26, DMP is in line with its industry, outperforming 43.64% of the companies in the same industry.
DMP has a debt to FCF ratio of 6.15. This is a slightly negative value and a sign of low solvency as DMP would need 6.15 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.15, DMP is in line with its industry, outperforming 43.64% of the companies in the same industry.
A Debt/Equity ratio of 1.44 is on the high side and indicates that DMP has dependencies on debt financing.
With a Debt to Equity ratio value of 1.44, DMP is not doing good in the industry: 76.36% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.44 | ||
| Debt/FCF | 6.15 | ||
| Altman-Z | 2.26 |
ROIC/WACC1.16
WACC6.28%
2.3 Liquidity
A Current Ratio of 2.20 indicates that DMP has no problem at all paying its short term obligations.
The Current ratio of DMP (2.20) is better than 74.55% of its industry peers.
DMP has a Quick Ratio of 1.04. This is a normal value and indicates that DMP is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of DMP (1.04) is better than 63.64% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.2 | ||
| Quick Ratio | 1.04 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 28.01% over the past year.
DMP shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.07% yearly.
DMP shows a small growth in Revenue. In the last year, the Revenue has grown by 0.11%.
The Revenue has been growing by 11.00% on average over the past years. This is quite good.
EPS 1Y (TTM)28.01%
EPS 3Y-18.42%
EPS 5Y8.07%
EPS Q2Q%26.56%
Revenue 1Y (TTM)0.11%
Revenue growth 3Y7.79%
Revenue growth 5Y11%
Sales Q2Q%-5.36%
3.2 Future
Based on estimates for the next years, DMP will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.68% on average per year.
Based on estimates for the next years, DMP will show a small growth in Revenue. The Revenue will grow by 3.09% on average per year.
EPS Next Y12.59%
EPS Next 2Y11.78%
EPS Next 3Y11.05%
EPS Next 5Y14.68%
Revenue Next Year-0.83%
Revenue Next 2Y1.53%
Revenue Next 3Y2.28%
Revenue Next 5Y3.09%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 17.79 indicates a rather expensive valuation of DMP.
Compared to the rest of the industry, the Price/Earnings ratio of DMP indicates a somewhat cheap valuation: DMP is cheaper than 61.82% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of DMP to the average of the S&P500 Index (27.19), we can say DMP is valued slightly cheaper.
The Price/Forward Earnings ratio is 14.97, which indicates a correct valuation of DMP.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DMP indicates a somewhat cheap valuation: DMP is cheaper than 67.27% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of DMP to the average of the S&P500 Index (23.88), we can say DMP is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.79 | ||
| Fwd PE | 14.97 |
4.2 Price Multiples
78.18% of the companies in the same industry are more expensive than DMP, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, DMP is valued cheaply inside the industry as 83.64% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.52 | ||
| EV/EBITDA | 9.74 |
4.3 Compensation for Growth
DMP's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.41
PEG (5Y)2.2
EPS Next 2Y11.78%
EPS Next 3Y11.05%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.29%, DMP has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 1.60, DMP pays a bit more dividend than its industry peers.
DMP's Dividend Yield is comparable with the S&P500 average which is at 1.94.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.29% |
5.2 History
The dividend of DMP has a limited annual growth rate of 2.71%.
Dividend Growth(5Y)2.71%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
41.76% of the earnings are spent on dividend by DMP. This is a bit on the high side, but may be sustainable.
DMP's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP41.76%
EPS Next 2Y11.78%
EPS Next 3Y11.05%
FRA:DMP (1/9/2026, 7:00:00 PM)
38.25
-0.5 (-1.29%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners11.57%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.06B
Revenue(TTM)1.16B
Net Income(TTM)116.03M
Analysts78.18
Price Target42.84 (12%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.29% |
Yearly Dividend0.88
Dividend Growth(5Y)2.71%
DP41.76%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.94%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.36%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.79 | ||
| Fwd PE | 14.97 | ||
| P/S | 1.78 | ||
| P/FCF | 12.52 | ||
| P/OCF | 9.97 | ||
| P/B | 3.17 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.74 |
EPS(TTM)2.15
EY5.62%
EPS(NY)2.56
Fwd EY6.68%
FCF(TTM)3.05
FCFY7.98%
OCF(TTM)3.84
OCFY10.03%
SpS21.55
BVpS12.06
TBVpS-7.73
PEG (NY)1.41
PEG (5Y)2.2
Graham Number24.15
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.48% | ||
| ROE | 17.87% | ||
| ROCE | 11.89% | ||
| ROIC | 7.26% | ||
| ROICexc | 7.91% | ||
| ROICexgc | 21.74% | ||
| OM | 18.7% | ||
| PM (TTM) | 10% | ||
| GM | 66.57% | ||
| FCFM | 14.17% |
ROA(3y)5.95%
ROA(5y)7.95%
ROE(3y)18.55%
ROE(5y)24.89%
ROIC(3y)9.78%
ROIC(5y)10.35%
ROICexc(3y)10.97%
ROICexc(5y)11.73%
ROICexgc(3y)29.64%
ROICexgc(5y)29.05%
ROCE(3y)16.03%
ROCE(5y)16.96%
ROICexgc growth 3Y-9.69%
ROICexgc growth 5Y2.94%
ROICexc growth 3Y-20.13%
ROICexc growth 5Y-1%
OM growth 3Y-14.93%
OM growth 5Y2.07%
PM growth 3Y-24.31%
PM growth 5Y-2.64%
GM growth 3Y-0.44%
GM growth 5Y3.48%
F-Score7
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.44 | ||
| Debt/FCF | 6.15 | ||
| Debt/EBITDA | 3.09 | ||
| Cap/Depr | 49.31% | ||
| Cap/Sales | 3.63% | ||
| Interest Coverage | 4.01 | ||
| Cash Conversion | 68.3% | ||
| Profit Quality | 141.71% | ||
| Current Ratio | 2.2 | ||
| Quick Ratio | 1.04 | ||
| Altman-Z | 2.26 |
F-Score7
WACC6.28%
ROIC/WACC1.16
Cap/Depr(3y)41.99%
Cap/Depr(5y)70.86%
Cap/Sales(3y)3.57%
Cap/Sales(5y)4.47%
Profit Quality(3y)204.39%
Profit Quality(5y)161.92%
High Growth Momentum
Growth
EPS 1Y (TTM)28.01%
EPS 3Y-18.42%
EPS 5Y8.07%
EPS Q2Q%26.56%
EPS Next Y12.59%
EPS Next 2Y11.78%
EPS Next 3Y11.05%
EPS Next 5Y14.68%
Revenue 1Y (TTM)0.11%
Revenue growth 3Y7.79%
Revenue growth 5Y11%
Sales Q2Q%-5.36%
Revenue Next Year-0.83%
Revenue Next 2Y1.53%
Revenue Next 3Y2.28%
Revenue Next 5Y3.09%
EBIT growth 1Y5.29%
EBIT growth 3Y-8.31%
EBIT growth 5Y13.3%
EBIT Next Year57.22%
EBIT Next 3Y19.63%
EBIT Next 5Y7.73%
FCF growth 1Y-31.18%
FCF growth 3Y-4.81%
FCF growth 5Y24.67%
OCF growth 1Y-25.65%
OCF growth 3Y-7%
OCF growth 5Y14.89%
DERMAPHARM HOLDING SE / DMP.DE FAQ
What is the fundamental rating for DMP stock?
ChartMill assigns a fundamental rating of 5 / 10 to DMP.DE.
Can you provide the valuation status for DERMAPHARM HOLDING SE?
ChartMill assigns a valuation rating of 5 / 10 to DERMAPHARM HOLDING SE (DMP.DE). This can be considered as Fairly Valued.
How profitable is DERMAPHARM HOLDING SE (DMP.DE) stock?
DERMAPHARM HOLDING SE (DMP.DE) has a profitability rating of 5 / 10.
What are the PE and PB ratios of DERMAPHARM HOLDING SE (DMP.DE) stock?
The Price/Earnings (PE) ratio for DERMAPHARM HOLDING SE (DMP.DE) is 17.79 and the Price/Book (PB) ratio is 3.17.
Can you provide the expected EPS growth for DMP stock?
The Earnings per Share (EPS) of DERMAPHARM HOLDING SE (DMP.DE) is expected to grow by 12.59% in the next year.